Managing High-alert Medication Administration and Errors

Medication Safety Climate: Managing High-alert Medication Administration and Errors Among Nurses in Intensive and Critical Care Units

High-alert medications are drugs that may lead to serious harm when they are wrongly administered to patients. Safe medication administration is the crucial role of nursing staff.

Study Overview

• Status: Completed
• Conditions: Nurse's Role; Knowledge; Competence; Error Disclosure; Practice Nurse's Scope
• Intervention / Treatment: Other: high-alert medication administration

Detailed Description

High-alert medications are drugs that may lead to serious harm when they are wrongly administered to patients. Safe medication administration is the crucial role of nursing staff. This study aims to investigate the relationships between medication safety climate and nurses' knowledge about high-alert medications with managing their administration and errors.

• Study Type: Observational
• Enrollment (Actual): 300

Contacts and Locations

Study Locations

• Egypt
  • Mersa Matruh, Egypt, 002
    • Faculty of Nursing, Matrouh University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

A sample of 300 nurses was enrolled in the current study. The nurses were willing to participate in the study and provided their agreement by informed consent.

Description

Inclusion Criteria:

• Nurses

  • willing to participate in the study
  • work in surgical intensive and critical care units
  • Sign a consent

Exclusion Criteria:

- Nurses

• Work in outpatient units and other units
• Did not sign a consent

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
nurses; Nurses worked in surgical intensive and critical care units	Other: high-alert medication administration; high-alert medication administration

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Questionnaire to measure nurses' knowledge about high-alert medication administration	Nurses' knowledge about high-alert medication administration as assessed binary scale.	one month
Questionnaire to measure medication safety climate	Medication safety climate as assessed using five-point Likert scale ranging from strongly disagree (1 point) to strongly agree (5 points).	one month
Questionnaire to measure nurses' competency	Nurses' competency during the administration of high-alert medications as assessed using five- Likert scales ((0 = not appropriate at all in administering high-alert medications up to 4 = very often appropriate in administering high-alert medications)	one month
observational check list to measure nurses' practice during administration of high-alert medications	Observing nurses' practice during the administration of high alert medications as assessed using five Likert scales (0=inappropriate practice up to 4=appropriate practice)	one month
Questionnaire to measure errors associated with administering high-alert medications	Errors associated with administering high-alert medications as assessed using a binary scale ( Yes=1 , No=0)	one month

Collaborators and Investigators

• Sponsor: Matrouh University
• Investigators: Study Director: Wael M. Lotfy, Ph.D, Faculty of Nursing, Matrouh University, Egypt; Principal Investigator: Nagah Abd El-Fattah Mohamed Aly, Ph.D, Faculty of Nursing, Matrouh University, Egypt; Study Chair: Safaa M. El-Shanawany, Ph.D, Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Alexandria University, Egypt; Study Chair: Maha Ghanem, Ph.D, Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Alexandria University, Egypt; Principal Investigator: Hanaa Abbass, Ph.D, Psychatric Nursing and Mental health , Faculty of Nursing, Alexandria University, Egypt; Principal Investigator: Maysa Elbiaa, Ph.D, Faculty of Nursing, Matrouh University , Egypt

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2023
• Primary Completion (Actual): May 31, 2023
• Study Completion (Actual): May 31, 2023

Study Registration Dates

• First Submitted: April 3, 2024
• First Submitted That Met QC Criteria: April 13, 2024
• First Posted (Actual): April 16, 2024

Study Record Updates

• Last Update Posted (Actual): April 16, 2024
• Last Update Submitted That Met QC Criteria: April 13, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Keywords: Administration; Errors; Nurses' role; Medication safety climate; Managing, High-alert medication
• Other Study ID Numbers: 0306066

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No